- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02696915
Fascia Iliaca Compartment Block for Proximal-end Femur Fractures
Fascia Iliaca Compartment Block in Proximal End Femur Fractures, Does it Make a Difference?
Fracture femur is a common injury which is associated with excruciating pain. Positioning for neuraxial blocks is always challenging because even slight overriding of the fracture ends is intensely painful .It can causing major patient distress which accompanied by well-known physiological sequelae such as sympathetic activation causing tachycardia, hypotension, and increased cardiac work that may compromise high-risk cardiac patients.
Fascia iliaca compartment block is highly effective in blocking lateral cutaneous nerve of the thigh and femoral nerve. Fascia iliaca compartment block is not only easy to perform but it is also associated with minimal risk as the local anesthetic is injected at a safe distance from the femoral artery and femoral nerve. It is always safe to perform the fascia iliaca compartment block prior to spinal anesthesia as the patient can respond during administration of the local anesthetic and can prevent intra-neuronal injections
Study Overview
Status
Conditions
Detailed Description
On arrival to the pre-operative holding area half hour before the scheduled surgery. Patient will be connected to basal monitoring devices; pulse oximetry and non- invasive blood pressure. Fascia iliaca compartment block will be performed with the aid of ultrasound device in all cases.The injected local anesthetic solution will be prepared by a staff member who was not involved in the study) according to the randomization. After 20 minutes from the injection the investigators will assessed nerves that had been blocked.
On arrival to the operative theater, under complete aseptic technique spinal anesthesia will be carried out in the sitting position (if there is severe pain at positioning we will use lateral position) at space between L3-4 or L4-5 using a 25-gauge spinal quincke needle. After feeling the desired space, the needle will be advanced (paramedian approach) till free flow of cerebrospinal fluid dropped from the needle then 15 mg hyperbaric bupivacaine+20mic fentanyl will be injected.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
DK
-
Mansoura, DK, Egypt, 050
- Mansoura University Hospitals
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- American Society of Anesthesiologist physical status I to III
- Patients scheduled for fixation for proximal end femur fracture
Exclusion Criteria:
- Patients refusal
- Morbid obese patients (BMI>40)
- Bleeding diathesis
- Previous femoral bypass surgery
- Inguinal hernia
- Inflammation/infection over injection site
- Peripheral neuropathy
- Allergy to local anesthetics agents used.
- Severely altered consciousness level
- Psychiatric disorders
- Polytrauma
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo
Patients received ultrasound guided fascia iliaca compartment block using 40 ml of saline 0.9%.
Then intrathecal medications will be administered.
|
Patients received ultrasound guided fascial iliaca compartment blockade using normal saline 0.9%, 40 ml
Ultrasound guided fascia iliaca compartment block
Intrathecal hyperbaric bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms
|
Active Comparator: Bupivacaine
Patients received ultrasound guided fascia iliaca compartment block using 40 ml of 0.25% bupivacaine.
Then intrathecal medications will be administered.
|
Ultrasound guided fascia iliaca compartment block
Intrathecal hyperbaric bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms
Patients received ultrasound guided fascial iliaca compartment blockade using bupivacaine 0.25%, 40 ml
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain scores
Time Frame: For 24 hours after performance the blockade
|
Pain was assessed using visual analogue score
|
For 24 hours after performance the blockade
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart rate
Time Frame: For 24 hours after performance the blockade
|
For 24 hours after performance the blockade
|
|
Blood pressure
Time Frame: For 24 hours after performance the blockade
|
For 24 hours after performance the blockade
|
|
Peripheral oxygen saturation
Time Frame: For 24 hours after performance the blockade
|
For 24 hours after performance the blockade
|
|
Time to performing spinal anesthesia
Time Frame: For 30 min after placement of patient in the optimum position
|
Time from the placement of patient in the optimum position to the intra-thecal injection of bupivacaine
|
For 30 min after placement of patient in the optimum position
|
Number of trials of dural puncture
Time Frame: For 30 min after placement of patient in the optimum position
|
For 30 min after placement of patient in the optimum position
|
|
Duration of motor blockade
Time Frame: For 12 hours after performing spinal anesthesia
|
For 12 hours after performing spinal anesthesia
|
|
Duration of sensory blockade
Time Frame: For 12 hours after performing spinal anesthesia
|
For 12 hours after performing spinal anesthesia
|
|
Duration of analgesia
Time Frame: For 24 hours after performing spinal anesthesia
|
Time from performing spinal anesthesia to first analgesic request
|
For 24 hours after performing spinal anesthesia
|
Cumulative consumption of analgesics
Time Frame: For 24 hours after performing spinal anesthesia
|
Total opioid or other analgesics received for the first 24 hours after surgery.
|
For 24 hours after performing spinal anesthesia
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Reem A El Sharkawy, MD, Lecturer of anesthesia and surgical intensive care
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Wounds and Injuries
- Leg Injuries
- Femoral Fractures
- Fractures, Bone
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Adjuvants, Anesthesia
- Anesthetics, Local
- Fentanyl
- Bupivacaine
Other Study ID Numbers
- MS/811
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Proximal Femur Fractures
-
AO Clinical Investigation and Publishing DocumentationCompletedProximal Femur FracturesUnited States, Switzerland, Austria
-
Ibn Jazzar HospitalCompletedProximal Femur FracturesTunisia
-
Hadassah Medical OrganizationUnknownProximal Femur FractureIsrael
-
Hospital Regional TlalnepantlaCompleted
-
Jenny BajracharyaUnknownFracture of Proximal End of FemurNepal
-
Synthes GmbHSynthes Australia Pty LtdWithdrawnProximal or Diaphyseal Humerus Fracture | Diaphyseal or Distal Femur Fracture | Diaphyseal, Distal or Proximal Tibia FractureAustralia
-
Mansoura UniversityUnknown
-
Mansoura UniversityCompleted
-
University Hospital OstravaRecruitingProximal Femur FractureCzechia
-
The University of Hong KongRecruitingProximal Humeral Fracture | Distal Humerus Fracture | Distal Femur Fracture | Distal Tibia FractureHong Kong
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States